对帕金森病的临床个性化药物和对睡眠功能障碍的影响
Vinod Metta1, Karolina Popławska-Domaszewicz2, Rosabel Chen3
1Parkinson's Centre of Excellence King's College Hospital, London, UK; King's College Hospital, London Dubai, Dubai Hills, Dubai, UAE.
Sleep medicine clinics
|September 5, 2025
概括
对帕金森病 (PD) 的个性化药物使用遗传学和患者因素来定制治疗. 这种方法优化了运动和非运动症状的治疗,改善了患者的治疗结果.
科学领域:
- 神经学
- 药物基因组学
- 个性化医疗
背景情况:
- 帕金森病需要个性化的治疗方法.
- 非运动症状,如睡眠功能障碍, 显著影响PD患者的生活质量.
- 遗传因素和患者特征影响了PD的进展和治疗反应.
研究的目的:
- 探索个性化医疗 (PM) 在帕金森病 (PD) 中的多方面的应用.
- 突出精确疗法和药物遗传学在患病管理中的作用.
- 强调整合患者特异性数据以优化PD护理.
主要方法:
- 对PD个性化医疗的最新文献的审查.
- 对基因组数据的分析及其针对性治疗的影响.
- 考虑非遗传因素,如年龄,运动和相关疾病.
主要成果:
- 基于基因组的疗法, 如安布洛克索尔治疗GBA突变性病症,
- 药物遗传学可以确定对特定副作用的易感性,例如突然开始睡眠.
- 患者特异性因素 (年龄,运动,并发症) 对于管理PD睡眠质量至关重要.
结论:
- 个性化医疗为帕金森病提供了量身定制的策略.
- 综合遗传学,药物遗传学和临床数据可以改善PD治疗.
- 一个全面的"帕金森仪表板"方法是PD有效的PM的关键.
相关概念视频
Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
REM Sleep Behavior Disorder
378
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
378
Substance Use Disorders Affecting Sleep
216
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
216
Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123


